Alpha Paradigm Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,850
Closed -$1.51M 486
2022
Q3
$1.51M Buy
+17,850
New +$1.51M 0.66% 27
2022
Q2
Sell
-8,855
Closed -$683K 508
2022
Q1
$683K Sell
8,855
-2,358
-21% -$182K 0.27% 112
2021
Q4
$991K Sell
11,213
-8,013
-42% -$708K 0.4% 59
2021
Q3
$1.49M Buy
+19,226
New +$1.49M 0.6% 31